[NKTR] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -20.67%
YoY- -23.72%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 24,822 23,647 50,573 28,222 38,018 24,728 58,882 -13.40%
PBT -90,267 -122,875 -138,451 -119,495 -95,527 -63,733 -19,331 29.26%
Tax 126 92 200 -983 265 133 167 -4.58%
NP -90,393 -122,967 -138,651 -118,512 -95,792 -63,866 -19,498 29.11%
Tax Rate - - - - - - - -
Total Cost 115,215 146,614 189,224 146,734 133,810 88,594 78,380 6.62%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -364.16 -520.01 -274.16 -419.93 -251.96 -258.27 -33.11 49.09%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.49 -0.68 -0.78 -0.68 -0.60 -0.42 -0.14 23.20%
EPS Diluted -0.49 -0.68 -0.78 -0.68 -0.60 -0.42 -0.14 23.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.